相关实验视频
Updated: Jun 5, 2025

08:40
Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
7.0K
囊性纤维化风险变体提供了对炎症性肠道疾病的保护
Mingrui Yu1,2, Qian Zhang3, Kai Yuan1,2
1Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, USA.
medRxiv : the preprint server for health sciences
|December 16, 2024
概括
在CFTR基因中的囊性纤维化风险变异似乎可以预防炎症性肠病 (IBD). 这项研究利用了大量的外基因组测序数据来证实这种保护性关联,突出了需要更好的变异优先级工具的需求.
科学领域:
- 遗传学 是一个遗传学.
- 胃肠病学 胃肠病学
- 医学研究 医学研究
背景情况:
- 囊性纤维化是由CFTR基因的遗传突变引起的.
- 已经提出了CFTR功能丧失突变对炎症性肠病 (IBD) 的潜在保护作用,但仍在争论中.
- 之前关于CFTR变异和IBD风险的研究已经产生了不确定的和矛盾的结果.
研究的目的:
- 调查囊性纤维化跨膜调节器 (CFTR) 基因变异与发展炎症性肠病 (IBD) 的风险之间的关联.
- 利用大规模的外基因组测序数据集,提供强有力的证据支持或反对CF风险变异在IBD中的保护作用.
- 在IBD基因负担测试的背景下,评估变异优先级方法的性能.
主要方法:
- 利用了最大的可用的IBD外基因组测序数据集,包括38558例IBD发现病例和66945例控制病例,以及35797例IBD复制病例和179942例控制病例.
- 对特定CFTR变异进行关联测试,如delF508.8.
- 对CF风险变体进行基因负担测试,以评估整体遗传贡献.
- 评估变异优先级工具,包括AlphaMissense,使用临床注释的CF风险变异作为基准.
主要成果:
- 确立了CF风险变异对IBD的统计学上显著的保护作用.
- 对CFTR delF508的关联测试显示出强烈的保护作用 (p值=8.96E-11).
- 对CF风险变异的基因负担测试也表明了显著的保护性关联 (p值=3.9E-07).
结论:
- 结核病风险变体显示出对炎症性肠道疾病的保护作用.
- 这些发现强调了CFTR基因变异在调节IBD风险方面的重要性.
- 在复杂疾病的基因负担分析中,对改进的变异优先级方法有着至关重要的和未得到满足的需求.
相关概念视频
Cystic Fibrosis: Pathogenesis
185
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
185
Cystic Fibrosis: Management
139
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
139
Inflammatory Bowel Disease II: Crohn's Disease
183
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
183
Inflammatory Bowel Disease I: Ulcerative Colitis
135
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
135
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
315
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
315
Chronic Bowel Disorders: Introduction
386
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
386

